Trump administration unveils Medicare negotiated price cuts for 15 drugs, including Ozempic

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved compared to last year’s spending.  The medications include widely used cancer and diabetes drugs, inhalers, and GLP-1 medications Ozempic and Wegovy — the drugs Medicare spends the most on. The negotiated…